Spots Global Cancer Trial Database for basiliximab
Every month we try and update this database with for basiliximab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma | NCT01476839 | Recurrent Adult... | basiliximab carmustine etoposide cytarabine melphalan pharmacological... laboratory biom... autologous hema... yttrium Y 90-la... | 18 Years - 70 Years | City of Hope Medical Center | |
| Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission | NCT01842139 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... | basiliximab WT1 126-134 pep... Montanide ISA 5... poly ICLC laboratory biom... | 18 Years - 85 Years | University of Chicago | |
| Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission | NCT01842139 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... | basiliximab WT1 126-134 pep... Montanide ISA 5... poly ICLC laboratory biom... | 18 Years - 85 Years | University of Chicago | |
| Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer | NCT00975975 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Non-Hodgkin's L... Hodgkin's Disea... Multiple Myelom... Myelofibrosis Anemia, Aplasti... Hemoglobinuria,... | Basiliximab | 18 Years - | Indiana University | |
| Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission | NCT01842139 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... | basiliximab WT1 126-134 pep... Montanide ISA 5... poly ICLC laboratory biom... | 18 Years - 85 Years | University of Chicago | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia | NCT00626483 | Malignant Neopl... | RNA-loaded dend... basiliximab | 18 Years - 120 Years | Duke University | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer | NCT00975975 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Non-Hodgkin's L... Hodgkin's Disea... Multiple Myelom... Myelofibrosis Anemia, Aplasti... Hemoglobinuria,... | Basiliximab | 18 Years - | Indiana University | |
| Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia | NCT00626483 | Malignant Neopl... | RNA-loaded dend... basiliximab | 18 Years - 120 Years | Duke University | |
| DC Migration Study for Newly-Diagnosed GBM | NCT02366728 | Glioblastoma Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... | Unpulsed DCs Td Human CMV pp65-... 111In-labeled D... Temozolomide Saline Basiliximab | 18 Years - 80 Years | Duke University | |
| In-Vivo Activated T-Cell Depletion to Prevent GVHD | NCT00594308 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Lymphoma, Non-H... Mantle-Cell Lym... Hodgkin's Disea... Multiple Myelom... Myelofibrosis | Cyclophosphamid... Fludarabine Cyclosporine Mycophenolate m... Basiliximab | 18 Years - 75 Years | Indiana University | |
| Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma | NCT04871607 | Recurrent Hodgk... Refractory Hodg... | Basiliximab Carmustine Cytarabine Etoposide Genetically Eng... Recombinant Gra... Yttrium Y 90 Ba... | 18 Years - | City of Hope Medical Center | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center | |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome | NCT05139004 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Secondary Acute... | Allogeneic Hema... Basiliximab Fludarabine Pho... Indium In 111-D... Melphalan Palifermin Total Lymphoid ... Total Marrow Ir... Yttrium Y 90 Ba... | 60 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
